https://patentmonetize.com/pat....ent-troll-litigation

https://patentmonetize.com/cre....do-technology-patent

https://patentmonetize.com/act....imed-therapeutics-pa

Patent monetization continues to fuel global healthcare innovation, and the latest example is the Mankind Pharma and Actimed Therapeutics patent licensing deal. Mankind has secured exclusive rights to develop and market Actimed’s experimental cachexia drug, ACM-001.1, a potential breakthrough for cancer-related muscle wasting. This partnership highlights how strategic patent licensing can accelerate treatment access and drive medical advancement.

https://patentmonetize.com/rev....ocation-of-patent-li

https://patentmonetize.com/vol....untary-licensing-vs-